Your browser doesn't support javascript.
Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
Kuhlmann, Constanze; Mayer, Carla Konstanze; Claassen, Mathilda; Maponga, Tongai; Burgers, Wendy A; Keeton, Roanne; Riou, Catherine; Sutherland, Andrew D; Suliman, Tasnim; Shaw, Megan L; Preiser, Wolfgang.
  • Kuhlmann C; Division of Hand, Plastic and Aesthetic Surgery, University Hospital, LMU Munich, Munich, Germany.
  • Mayer CK; Division of Medical Virology, Faculty of Medicine and Health Sciences, University of Stellenbosch Tygerberg Campus, Cape Town ZA-7505, South Africa.
  • Claassen M; Medical Virology, National Health Laboratory Service Tygerberg, Parow, Cape Town, South Africa.
  • Maponga T; Division of Medical Virology, Faculty of Medicine and Health Sciences, University of Stellenbosch Tygerberg Campus, Cape Town ZA-7505, South Africa.
  • Burgers WA; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
  • Keeton R; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
  • Riou C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Observatory, Cape Town, South Africa.
  • Sutherland AD; Division of Medical Virology, Faculty of Medicine and Health Sciences, University of Stellenbosch Tygerberg Campus, Cape Town ZA-7505, South Africa.
  • Suliman T; Department of Medical Biosciences, University of the Western Cape, Cape Town, South Africa.
  • Shaw ML; Department of Medical Biosciences, University of the Western Cape, Cape Town, South Africa.
  • Preiser W; Division of Medical Virology, Faculty of Medicine and Health Sciences, University of Stellenbosch Tygerberg Campus, Cape Town ZA-7505, South Africa; Medical Virology, National Health Laboratory Service Tygerberg, Parow, Cape Town, South Africa. Electronic address: preiser@sun.ac.za.
Lancet ; 399(10325): 625-626, 2022 02 12.
Article in English | MEDLINE | ID: covidwho-1721147
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 / ChAdOx1 nCoV-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Adult / Female / Humans / Male Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(22)00090-3

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / BNT162 Vaccine / 2019-nCoV Vaccine mRNA-1273 / ChAdOx1 nCoV-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Adult / Female / Humans / Male Language: English Journal: Lancet Year: 2022 Document Type: Article Affiliation country: S0140-6736(22)00090-3